| Studies show that in the context of Myc-associated tumorigenesis, loss of Wrn amplifies the DNA damage response, both in preneoplastic and neoplastic tissue, engaging activation of tumor suppressor pathways. | None |
| Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. | None |
| The disease is associated with Epstein-Barr virus and was one of the first tumours shown to have a chromosomal translocation that activates an oncogene (c-MYC). | None |
| A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS. | None |
| Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. | None |
| [The sensitivity to growth factors of NIH 3T3 cells transformed by the v-myc oncogene]. | None |
| Expression of the avian gag-myc oncogene in Saccharomyces cerevisiae. | None |
| Proto-Oncogene Proteins c-myc controls c-MYC controls transcription of MCL1 directly, regulation of BCL(XL) was due to c-MYC_s capability to regulate the eIF4E gene, which encodes a rate-limiting factor of eukaryotic translation. | None |
| Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. | None |
| Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. | None |
| Novel c-Myc targeted genes were identified and may contribute to hepatocyte transformation by altering cell cycle control, thereby contributing to c-Myc_s oncogenic activity. | None |
| Spontaneous DNA lesions modulate DNA structural transitions occurring at nuclease hypersensitive element III(1) of the human c-myc proto-oncogene. | None |
| Mapping of translocation breakpoints using an acetylated histone H3 lysine 9 chromatin immunoprecipitation sequencing approach reveals Igh fusions up to approximately 350 kb upstream of Myc or the related oncogene Mycn in Burkitt translocations. | None |
| Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation. | None |
| Detection of C-MYC oncogene translocation and copy number change in the normal-dysplasia-carcinoma sequence of the larynx by fluorescence in situ hybridization. | None |
| MYC oncogene in myeloid neoplasias. | None |
| Oncogene addiction to c-MYC in myeloma cells. | None |
| The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. | None |
| c-myc proto-oncogene expression in peripheral blood mononuclear cells from patients with primary Sjogren s syndrome. | None |
| The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations. | None |